Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 3.70886 | 61 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 3.53672 | 59 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 3.57136 | 60 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 3.46115 | 58 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 3.44517 | 58 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 4.26977 | 69 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 3.74616 | 61 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 3.53153 | 59 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 3.52587 | 59 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 3.48828 | 58 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 3.55106 | 59 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 3.48315 | 58 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 3.60883 | 60 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 3.55677 | 59 |